This study is not yet accepting patients
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedstudy ends around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Boehringer Ingelheim
- Links
- Related Info
- ID
- NCT07915219
- Phase
- Phase 3 Bronchiectasis Research Study
- Study Type
- Interventional
- Participants
- Expecting 1500 study participants
- Last Updated